Please wait while the formulary information is being retrieved.
CHILDREN'S ALLERGY RELIEF (LORATADINE)
- Allergic reaction
- Allergic rhinitis
- Chronic idiopathic urticaria
- Insomnia
- Allergic conjunctivitis
- Allergic rhinitis
- Anaphylaxis
- Cough
- Dermatographic urticaria
- Idiopathic parkinsonism
- Motion sickness
- Nasal congestion
- Nausea
- Nausea and vomiting
- Parkinsonism
- Perennial allergic rhinitis
- Pruritus of skin
- Seasonal allergic rhinitis
- Sneezing
- Urticaria
- Vertigo
- Vomiting
- Wal-zyr Oral Solution
- Wal-zyr (cetirizine) Oral Solution
- Wal-itin Oral Solution
- Wal-dryl Allergy Oral Liquid
- Siladryl Sa Oral Liquid
- M-dryl Oral Liquid
- Loratadine Oral Solution
- Geri-dryl Oral Liquid
- Fexofenadine Oral Suspension
- Diphenhydramine Oral Liquid
- Diphedryl Oral Liquid
- Diphedryl Allergy Oral Liquid
- Claritin Oral Solution
- Children's Zyrtec Allergy Oral Solution
- Children's Wal-zyr Oral Solution
- Children's Wal-fex Oral Suspension
- Children's Wal-dryl Allergy Oral Liquid
- Children's Wal-dryl Allergy Disintegrating Tablet
- Children's Claritin Oral Solution
- Children's Cetirizine Oral Solution
- Children's Allergy Relief Oral Solution
- Children's Allergy Relief (loratadine) Oral Solution
- Children's Allergy Relief (fexofenadine) Oral Suspension
- Children's Allergy Relief (diphenhyd) Disintegrating Tablet
- Children's Allergy Relief (cetirizine) Oral Solution
- Children's Allergy Relief (cetirizine) Oral Soln
- Children's Allergy (diphenhydramine) Oral Liquid
- Children's Allergy (cetirizine) Oral Solution
- Children's Allegra Allergy Oral Suspension
- Children's All Day Allergy (cetirizine) Oral Solution
- Cetirizine Oral Solution
- Cetirizine Oral Soln
- Benadryl Allergy Oral Liquid
- Allergy Relief Oral Soln
- Allergy Relief Oral Liquid
- Allergy Relief (loratadine) Oral Solution
- Allergy Relief (loratadine) Oral Soln
- Allergy Relief (diphenhydramine) Oral Liquid
- Allergy Relief (cetirizine) Oral Solution
- Allergy (diphenhydramine) Oral Liquid
- All Day Allergy (cetirizine) Oral Solution
- All Day Allergy (cetirizine) Oral Soln
- By Indication
(cetirizine) 1 mg/mL oral solution
- 10 milliliters (10 mg) by oral route once daily
(cetirizine) 1 mg/mL oral solution
- 10 milliliters (10 mg) by oral route once daily
5 mg/5 mL oral solution
- 10 milliliters (10 mg) by oral route once daily
12.5 mg/5 mL oral liquid
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
SA 12.5 mg/5 mL oral liquid
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
12.5 mg/5 mL oral liquid
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
5 mg/5 mL oral solution
- 10 milliliters (10 mg) by oral route once daily
loratadine 5 mg/5 mL oral solution
- 10 milliliters (10 mg) by oral route once daily
12.5 mg/5 mL oral liquid
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
fexofenadine 30 mg/5 mL oral suspension
- Dosage information is not available
diphenhydramine 12.5 mg/5 mL oral liquid
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
diphenhydramine 50 mg/30 mL oral liquid
- Dosage information is not available
12.5 mg/5 mL oral liquid
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
12.5 mg/5 mL oral liquid
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
5 mg/5 mL oral solution
- 10 milliliters (10 mg) by oral route once daily
Allergy 1 mg/mL oral solution
- 10 milliliters (10 mg) by oral route once daily
1 mg/mL oral solution
- 10 milliliters (10 mg) by oral route once daily
30 mg/5 mL oral suspension
- Dosage information is not available
12.5 mg/5 mL oral liquid
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
12.5 mg disintegrating tablet
- Dosage information is not available
5 mg/5 mL oral solution
- 10 milliliters (10 mg) by oral route once daily
Children's Cetirizine 1 mg/mL oral solution
- 10 milliliters (10 mg) by oral route once daily
(loratadine) 5 mg/5 mL oral solution
- 10 milliliters (10 mg) by oral route once daily
(loratadine) 5 mg/5 mL oral solution
- 10 milliliters (10 mg) by oral route once daily
Children's Allergy Relief (loratadine) 5 mg/5 mL oral solution
- 10 milliliters (10 mg) by oral route once daily
Relief (loratadine) 5 mg/5 mL oral solution
- 10 milliliters (10 mg) by oral route once daily
(fexofenadine) 30 mg/5 mL oral suspension
- Dosage information is not available
(diphenhyd) 12.5 mg disintegrating tablet
- Dosage information is not available
Children's Allergy Relief (diphenhyd) 12.5 mg disintegrating tablet
- Dosage information is not available
(cetirizine) 1 mg/mL oral solution
- 10 milliliters (10 mg) by oral route once daily
Children's Allergy Relief (cetirizine) 1 mg/mL oral solution
- 10 milliliters (10 mg) by oral route once daily
Relief (cetirizine) 1 mg/mL oral solution
- 10 milliliters (10 mg) by oral route once daily
(diphenhydramine) 12.5 mg/5 mL oral liquid
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
Children's Allergy (diphenhydramine) 12.5 mg/5 mL oral liquid
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
(cetirizine) 1 mg/mL oral solution
- 10 milliliters (10 mg) by oral route once daily
30 mg/5 mL oral suspension
- Dosage information is not available
(cetirizine) 1 mg/mL oral solution
- 10 milliliters (10 mg) by oral route once daily
Children's All Day Allergy (cetirizine) 1 mg/mL oral solution
- 10 milliliters (10 mg) by oral route once daily
cetirizine 1 mg/mL oral solution
- 10 milliliters (10 mg) by oral route once daily
cetirizine 5 mg/5 mL oral solution
- Dosage information is not available
1 mg/mL oral solution
- 10 milliliters (10 mg) by oral route once daily
5 mg/5 mL oral solution
- Dosage information is not available
12.5 mg/5 mL oral liquid
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
(loratadine) 5 mg/5 mL oral solution
- 10 milliliters (10 mg) by oral route once daily
(diphenhydramine) 12.5 mg/5 mL oral liquid
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
(loratadine) 5 mg/5 mL oral solution
- 10 milliliters (10 mg) by oral route once daily
5 mg/5 mL oral solution
- 10 milliliters (10 mg) by oral route once daily
(diphenhydramine) 12.5 mg/5 mL oral liquid
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
Allergy Relief (diphenhydramine) 12.5 mg/5 mL oral liquid
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
Relief (diphenhydramine) 12.5 mg/5 mL oral liquid
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
(cetirizine) 1 mg/mL oral solution
- 10 milliliters (10 mg) by oral route once daily
(diphenhydramine) 12.5 mg/5 mL oral liquid
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
(cetirizine) 1 mg/mL oral solution
- 10 milliliters (10 mg) by oral route once daily
1 mg/mL oral solution
- 10 milliliters (10 mg) by oral route once daily
1 mg/mL oral solution
- 10 milliliters (10 mg) by oral route once daily
Allergic conjunctivitis
- 10 milliliters (10 mg) by oral route once daily
- 10 milliliters (25 mg) by oral route every 4 hours
- 10 milliliters (25 mg) by oral route every 6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours as needed
- 10 milliliters (25 mg) by oral route every 4 hours as needed
- 10 milliliters (25 mg) by oral route every 6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours
- 20 milliliters (50 mg) by oral route every 6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours as needed
- 20 milliliters (50 mg) by oral route every 6 hours as needed
Allergic reaction
- 10 milliliters (25 mg) by oral route every 4-6 hours as needed
- 10 milliliters (25 mg) by oral route every 4 hours as needed
- 10 milliliters (25 mg) by oral route every 6 hours as needed
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours as needed
- 20 milliliters (50 mg) by oral route every 6 hours as needed
Allergic rhinitis
- 5 milliliters (5 mg) by oral route once daily
- 10 milliliters (10 mg) by oral route once daily
- 10 milliliters (25 mg) by oral route every 4 hours
- 10 milliliters (25 mg) by oral route every 6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours as needed
- 10 milliliters (25 mg) by oral route every 4 hours as needed
- 10 milliliters (25 mg) by oral route every 6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours
- 20 milliliters (50 mg) by oral route every 6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours as needed
- 20 milliliters (50 mg) by oral route every 6 hours as needed
Anaphylaxis
- 10 milliliters (25 mg) by oral route every 4 hours
- 10 milliliters (25 mg) by oral route every 6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours as needed
- 10 milliliters (25 mg) by oral route every 4 hours as needed
- 10 milliliters (25 mg) by oral route every 6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours
- 20 milliliters (50 mg) by oral route every 6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours as needed
- 20 milliliters (50 mg) by oral route every 6 hours as needed
Cough
- 10 milliliters (25 mg) by oral route every 4 hours
- 10 milliliters (25 mg) by oral route every 6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours as needed
- 10 milliliters (25 mg) by oral route every 4 hours as needed
- 10 milliliters (25 mg) by oral route every 6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours
- 20 milliliters (50 mg) by oral route every 6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours as needed
- 20 milliliters (50 mg) by oral route every 6 hours as needed
Dermatographic urticaria
- 10 milliliters (25 mg) by oral route every 4 hours
- 10 milliliters (25 mg) by oral route every 6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours as needed
- 10 milliliters (25 mg) by oral route every 4 hours as needed
- 10 milliliters (25 mg) by oral route every 6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours
- 20 milliliters (50 mg) by oral route every 6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours as needed
- 20 milliliters (50 mg) by oral route every 6 hours as needed
Drug-induced extrapyramidal reaction
- 10 milliliters (25 mg) by oral route 3 times per day
- 10 milliliters (25 mg) by oral route 4 times per day
- 20 milliliters (50 mg) by oral route 3 times per day
- 20 milliliters (50 mg) by oral route 4 times per day
Idiopathic parkinsonism
- 10 milliliters (25 mg) by oral route 3 times per day
- 20 milliliters (50 mg) by oral route 4 times per day
Insomnia
- 20 milliliters (50 mg) by oral route once daily at bedtime as needed
- 20 milliliters (50 mg) by oral route 20-30 minutes before bedtime if needed
Motion sickness
- 10 milliliters (25 mg) by oral route every 4-6 hours as needed
- 10 milliliters (25 mg) by oral route every 4 hours as needed
- 10 milliliters (25 mg) by oral route every 6 hours as needed
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours as needed
- 20 milliliters (50 mg) by oral route every 6 hours as needed
Nasal congestion
- 10 milliliters (25 mg) by oral route every 4 hours
- 10 milliliters (25 mg) by oral route every 6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours as needed
- 10 milliliters (25 mg) by oral route every 4 hours as needed
- 10 milliliters (25 mg) by oral route every 6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours
- 20 milliliters (50 mg) by oral route every 6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours as needed
- 20 milliliters (50 mg) by oral route every 6 hours as needed
Nausea
- 10 milliliters (25 mg) by oral route every 4 hours
- 10 milliliters (25 mg) by oral route every 6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours as needed
- 10 milliliters (25 mg) by oral route every 6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours
- 20 milliliters (50 mg) by oral route every 6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours as needed
- 20 milliliters (50 mg) by oral route every 6 hours as needed
Nausea and vomiting
- 10 milliliters (25 mg) by oral route every 4 hours
- 10 milliliters (25 mg) by oral route every 6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours as needed
- 10 milliliters (25 mg) by oral route every 6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours
- 20 milliliters (50 mg) by oral route every 6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours as needed
- 20 milliliters (50 mg) by oral route every 6 hours as needed
Parkinsonism
- 10 milliliters (25 mg) by oral route 3 times per day
- 10 milliliters (25 mg) by oral route 4 times per day
- 20 milliliters (50 mg) by oral route 3 times per day
- 20 milliliters (50 mg) by oral route 4 times per day
Pruritus of skin
- 10 milliliters (25 mg) by oral route every 4 hours
- 10 milliliters (25 mg) by oral route every 6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours as needed
- 10 milliliters (25 mg) by oral route every 4 hours as needed
- 10 milliliters (25 mg) by oral route every 6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours
- 20 milliliters (50 mg) by oral route every 6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours as needed
- 20 milliliters (50 mg) by oral route every 6 hours as needed
Sneezing
- 10 milliliters (10 mg) by oral route once daily
- 10 milliliters (25 mg) by oral route every 4 hours
- 10 milliliters (25 mg) by oral route every 6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours as needed
- 10 milliliters (25 mg) by oral route every 4 hours as needed
- 10 milliliters (25 mg) by oral route every 6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours
- 20 milliliters (50 mg) by oral route every 6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours as needed
- 20 milliliters (50 mg) by oral route every 6 hours as needed
Urticaria
- 5 milliliters (5 mg) by oral route once daily
- 10 milliliters (10 mg) by oral route once daily
- 10 milliliters (25 mg) by oral route every 4 hours
- 10 milliliters (25 mg) by oral route every 6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours as needed
- 10 milliliters (25 mg) by oral route every 4 hours as needed
- 10 milliliters (25 mg) by oral route every 6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours
- 20 milliliters (50 mg) by oral route every 6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours as needed
- 20 milliliters (50 mg) by oral route every 6 hours as needed
Vertigo
- 10 milliliters (25 mg) by oral route every 4 hours
- 10 milliliters (25 mg) by oral route every 6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours as needed
- 10 milliliters (25 mg) by oral route every 4 hours as needed
- 10 milliliters (25 mg) by oral route every 6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours
- 20 milliliters (50 mg) by oral route every 6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours as needed
- 20 milliliters (50 mg) by oral route every 6 hours as needed
Vomiting
- 10 milliliters (25 mg) by oral route every 4 hours
- 10 milliliters (25 mg) by oral route every 6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours
- 10 milliliters (25 mg) by oral route every 4-6 hours as needed
- 10 milliliters (25 mg) by oral route every 6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours
- 20 milliliters (50 mg) by oral route every 6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours
- 20 milliliters (50 mg) by oral route every 4-6 hours as needed
- 20 milliliters (50 mg) by oral route every 4 hours as needed
- 20 milliliters (50 mg) by oral route every 6 hours as needed
- None
Contraindicated
- Soltamox
- tamoxifen
Severe
Moderate
- None
- None
Contraindicated
- Angle-closure glaucoma
- Benign prostatic hyperplasia
- Bladder outflow obstruction
- Chronic idiopathic constipation
- Kidney disease with reduction in GFR
- Stenosing peptic ulcer
- Urinary retention
Severe
Moderate
- Disease of liver
- Glaucoma
- Hepatic failure
- Hypertension
- Hyperthyroidism
- Kidney disease with reduction in GFR
- Ocular hypertension
- Renal disease with moderate to severe impairment
- Urinary retention
CHILDREN'S ALLERGY RELIEF (LORATADINE)
- Allergic reaction
- Allergic rhinitis
- Chronic idiopathic urticaria
- Insomnia
- Allergic conjunctivitis
- Allergic rhinitis
- Anaphylaxis
- Cough
- Dermatographic urticaria
- Idiopathic parkinsonism
- Motion sickness
- Nasal congestion
- Nausea
- Nausea and vomiting
- Parkinsonism
- Perennial allergic rhinitis
- Pruritus of skin
- Seasonal allergic rhinitis
- Sneezing
- Urticaria
- Vertigo
- Vomiting
- None
- Dizziness
- Drowsy
- Dry nose
- Dry throat
- Headache disorder
- Thick bronchial secretions
- Xerostomia
More Frequent
Severe
Less Severe
- None
- Acute abdominal pain
- Back pain
- Conjunctivitis
- Dizziness
- Drowsy
- Dysmenorrhea
- Dyspepsia
- Fatigue
- Headache disorder
- Insomnia
- Myalgias
- Nausea
- Pharyngitis
- Sedation
- Sinusitis
- Skin rash
- Viral infection
- Vomiting
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Acute bacterial otitis media
- Acute generalized exanthematous pustulosis
- Anaphylaxis
- Angioedema
- Blood dyscrasias
- Bronchospastic pulmonary disease
- Cardiac arrhythmia
- Cholestasis
- Disease of liver
- Edema
- Extrasystoles
- Hallucinations
- Hemolytic anemia
- Hepatitis
- Hypersensitivity drug reaction
- Hypotension
- Palpitations
- Seizure disorder
- Tonic clonic seizure
- Upper respiratory infection
- Urticaria
Less Severe
- Abdominal distension
- Abdominal pain with cramps
- Acute abdominal pain
- Acute confusion
- Agitation
- Alopecia
- Anorexia
- Ataxia
- Blurred vision
- Bronchitis
- Chest discomfort
- Chills
- Concentration difficulty
- Constipation
- Cough
- Diarrhea
- Diplopia
- Dizziness
- Dream disorder
- Dry nose
- Dry throat
- Dyspnea
- Dysuria
- Earache
- Epistaxis
- Euphoria
- Excitement
- Fatigue
- Fever
- Gastritis
- Headache disorder
- Hyperhidrosis
- Hyperkinesis
- Increased appetite
- Insomnia
- Irritability
- Maculopapular rash
- Malaise
- Migraine
- Nausea
- Nervousness
- Nightmares
- Pain
- Palpitations
- Paresthesia
- Pharyngitis
- Pruritus of skin
- Sedation
- Skin photosensitivity
- Skin rash
- Symptoms of anxiety
- Tachycardia
- Tinnitus
- Tremor
- Unsteady gait
- Urinary incontinence
- Urinary retention
- Urticaria
- Vertigo
- Visual changes
- Voice change
- Weight gain
- Wheezing
- Xerostomia
Contraindicated
Diphenhydramine (Systemic)
Possible risk of CNS excitation, convulsions in newborns.
- 1 Day – 29 Days
- 1 Possible risk of CNS excitation, convulsions in newborns.
Severe Precaution
Diphenhydramine (Syst.antihist.)
Use with caution and with clinician consultation. Risk of adverse CNS effects includes sedation or paradoxical excitation.
Consult clinician for use age under 2 years. Safety and efficacy not established.
- 30 Days – 364 Days
- Use with caution and with clinician consultation. Risk of adverse CNS effects includes sedation or paradoxical excitation.
- 1 Day – 2 Years
- Use with caution and with clinician consultation. Risk of adverse CNS effects includes sedation or paradoxical excitation.
Loratadine
Use with caution and with clinician consultation. Risk of adverse CNS effects includes sedation or paradoxical excitation.
Consult clinician for use age under 2 years. Safety and efficacy not established.
- 30 Days – 364 Days
- Consult clinician for use age under 2 years. Safety and efficacy not established.
- 1 Day – 2 Years
- Consult clinician for use age under 2 years. Safety and efficacy not established.
Management or Monitoring Precaution
Cetirizine
Safety and efficacy not established in infants age <6 months.
Use with caution and with clinician consultation. Risk of adverse CNS effects include sedation or paradoxical excitation.
Safety & efficacy in children less than 6 months not established.
Increased incidence of vomiting, diarrhea, somnolence, rhinorrhea age < 5 years.
- 1 Day – 179 Days
- Safety and efficacy not established in infants age <6 months.
- 1 Years – 13 Years
- Safety and efficacy not established in infants age <6 months.
- 180 Days – 5 Years
- Safety and efficacy not established in infants age <6 months.
Diphenhydramine (Syst.antihist.)
Safety and efficacy not established in infants age <6 months.
Use with caution and with clinician consultation. Risk of adverse CNS effects include sedation or paradoxical excitation.
Safety & efficacy in children less than 6 months not established.
Increased incidence of vomiting, diarrhea, somnolence, rhinorrhea age < 5 years.
- 1 Day – 179 Days
- Use with caution and with clinician consultation. Risk of adverse CNS effects include sedation or paradoxical excitation.
- 1 Years – 13 Years
- Use with caution and with clinician consultation. Risk of adverse CNS effects include sedation or paradoxical excitation.
- 180 Days – 5 Years
- Use with caution and with clinician consultation. Risk of adverse CNS effects include sedation or paradoxical excitation.
Fexofenadine
Safety and efficacy not established in infants age <6 months.
Use with caution and with clinician consultation. Risk of adverse CNS effects include sedation or paradoxical excitation.
Safety & efficacy in children less than 6 months not established.
Increased incidence of vomiting, diarrhea, somnolence, rhinorrhea age < 5 years.
- 1 Day – 179 Days
- Safety & efficacy in children less than 6 months not established.
- Increased incidence of vomiting, diarrhea, somnolence, rhinorrhea age < 5 years.
- 1 Years – 13 Years
- Safety & efficacy in children less than 6 months not established.
- Increased incidence of vomiting, diarrhea, somnolence, rhinorrhea age < 5 years.
- 180 Days – 5 Years
- Safety & efficacy in children less than 6 months not established.
- Increased incidence of vomiting, diarrhea, somnolence, rhinorrhea age < 5 years.
Cetirizine
- Severity Level:
B
- Additional Notes:
Diphenhydramine
- Severity Level:
B
- Additional Notes:
Fexofenadine
- Severity Level:
2
- Additional Notes: Insufficient human data available.
Loratadine
- Severity Level:
B
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Cetirizine
Probably compatible per briggs;May cause sedation in nursing infant.
Limited data suggest increased drowsiness, and irritability
Insufficient data available; limited data suggest minimal amounts excreted
Limited data suggest low amounts excreted
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Probably compatible per briggs;May cause sedation in nursing infant. |
Diphenhydramine
Probably compatible per briggs;May cause sedation in nursing infant.
Limited data suggest increased drowsiness, and irritability
Insufficient data available; limited data suggest minimal amounts excreted
Limited data suggest low amounts excreted
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Limited data suggest increased drowsiness, and irritability |
Fexofenadine
Probably compatible per briggs;May cause sedation in nursing infant.
Limited data suggest increased drowsiness, and irritability
Insufficient data available; limited data suggest minimal amounts excreted
Limited data suggest low amounts excreted
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Insufficient data available; limited data suggest minimal amounts excreted |
Loratadine
Probably compatible per briggs;May cause sedation in nursing infant.
Limited data suggest increased drowsiness, and irritability
Insufficient data available; limited data suggest minimal amounts excreted
Limited data suggest low amounts excreted
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Limited data suggest low amounts excreted |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Cetirizine
Increased risk for neurological side effects. Dosage adjustment may be required.
Neuro/Psych-Anticholinergic effects may cause sedation, worsen cognitive impairment and increase fall risk. Maximum of 25mg/day. Cardiovascular-May cause orthostatic hypotension at higher doses. Gastrointestinal-May cause or worsen pre-existing constipation. Genitourinary-Best avoided in patients with urinary retention from any cause.
Decrease daily dose for declining renal function (CLCR<80ml/min).
Neuro/Psych-Avoid in older adults with or at high risk for delirium because of inducing or worsening delirium.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | N | Y | N | N |
BEERS: N HEDIS: N STOPP: N
Diphenhydramine
Increased risk for neurological side effects. Dosage adjustment may be required.
Neuro/Psych-Anticholinergic effects may cause sedation, worsen cognitive impairment and increase fall risk. Maximum of 25mg/day. Cardiovascular-May cause orthostatic hypotension at higher doses. Gastrointestinal-May cause or worsen pre-existing constipation. Genitourinary-Best avoided in patients with urinary retention from any cause.
Decrease daily dose for declining renal function (CLCR<80ml/min).
Neuro/Psych-Avoid in older adults with or at high risk for delirium because of inducing or worsening delirium.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | N | N | Y | N | N |
BEERS: Y HEDIS: Y STOPP: Y
Fexofenadine
Increased risk for neurological side effects. Dosage adjustment may be required.
Neuro/Psych-Anticholinergic effects may cause sedation, worsen cognitive impairment and increase fall risk. Maximum of 25mg/day. Cardiovascular-May cause orthostatic hypotension at higher doses. Gastrointestinal-May cause or worsen pre-existing constipation. Genitourinary-Best avoided in patients with urinary retention from any cause.
Decrease daily dose for declining renal function (CLCR<80ml/min).
Neuro/Psych-Avoid in older adults with or at high risk for delirium because of inducing or worsening delirium.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | N | N | N | N |
BEERS: N HEDIS: N STOPP: N
Loratadine
Increased risk for neurological side effects. Dosage adjustment may be required.
Neuro/Psych-Anticholinergic effects may cause sedation, worsen cognitive impairment and increase fall risk. Maximum of 25mg/day. Cardiovascular-May cause orthostatic hypotension at higher doses. Gastrointestinal-May cause or worsen pre-existing constipation. Genitourinary-Best avoided in patients with urinary retention from any cause.
Decrease daily dose for declining renal function (CLCR<80ml/min).
Neuro/Psych-Avoid in older adults with or at high risk for delirium because of inducing or worsening delirium.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | N | N | Y | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
| Allergic conjunctivitis | |
| H10.1 | Acute atopic conjunctivitis |
| H10.10 | Acute atopic conjunctivitis, unspecified eye |
| H10.11 | Acute atopic conjunctivitis, right eye |
| H10.12 | Acute atopic conjunctivitis, left eye |
| H10.13 | Acute atopic conjunctivitis, bilateral |
| H10.44 | Vernal conjunctivitis |
| H10.45 | Other chronic allergic conjunctivitis |
| H16.26 | Vernal keratoconjunctivitis, with limbar and corneal involvement |
| H16.261 | Vernal keratoconjunctivitis, with limbar and corneal involvement, right eye |
| H16.262 | Vernal keratoconjunctivitis, with limbar and corneal involvement, left eye |
| H16.263 | Vernal keratoconjunctivitis, with limbar and corneal involvement, bilateral |
| H16.269 | Vernal keratoconjunctivitis, with limbar and corneal involvement, unspecified eye |
| Allergic reaction | |
| T78.40 | Allergy, unspecified |
| T78.40xA | Allergy, unspecified, initial encounter |
| Allergic rhinitis | |
| J30.1 | Allergic rhinitis due to pollen |
| J30.2 | Other seasonal allergic rhinitis |
| J30.5 | Allergic rhinitis due to food |
| J30.8 | Other allergic rhinitis |
| J30.81 | Allergic rhinitis due to animal (cat) (dog) hair and dander |
| J30.89 | Other allergic rhinitis |
| J30.9 | Allergic rhinitis, unspecified |
| Anaphylaxis | |
| T78.0 | Anaphylactic reaction due to food |
| T78.00 | Anaphylactic reaction due to unspecified food |
| T78.00xA | Anaphylactic reaction due to unspecified food, initial encounter |
| T78.01 | Anaphylactic reaction due to peanuts |
| T78.01xA | Anaphylactic reaction due to peanuts, initial encounter |
| T78.02 | Anaphylactic reaction due to shellfish (crustaceans) |
| T78.02xA | Anaphylactic reaction due to shellfish (crustaceans), initial encounter |
| T78.03 | Anaphylactic reaction due to other fish |
| T78.03xA | Anaphylactic reaction due to other fish, initial encounter |
| T78.04 | Anaphylactic reaction due to fruits and vegetables |
| T78.04xA | Anaphylactic reaction due to fruits and vegetables, initial encounter |
| T78.05 | Anaphylactic reaction due to tree nuts and seeds |
| T78.05xA | Anaphylactic reaction due to tree nuts and seeds, initial encounter |
| T78.06 | Anaphylactic reaction due to food additives |
| T78.06xA | Anaphylactic reaction due to food additives, initial encounter |
| T78.07 | Anaphylactic reaction due to milk and dairy products |
| T78.07xA | Anaphylactic reaction due to milk and dairy products, initial encounter |
| T78.08 | Anaphylactic reaction due to eggs |
| T78.08xA | Anaphylactic reaction due to eggs, initial encounter |
| T78.09 | Anaphylactic reaction due to other food products |
| T78.09xA | Anaphylactic reaction due to other food products, initial encounter |
| T78.2 | Anaphylactic shock, unspecified |
| T78.2xxA | Anaphylactic shock, unspecified, initial encounter |
| T80.5 | Anaphylactic reaction due to serum |
| T80.51 | Anaphylactic reaction due to administration of blood and blood products |
| T80.51xA | Anaphylactic reaction due to administration of blood and blood products, initial encounter |
| T80.52 | Anaphylactic reaction due to vaccination |
| T80.52xA | Anaphylactic reaction due to vaccination, initial encounter |
| T80.59 | Anaphylactic reaction due to other serum |
| T80.59xA | Anaphylactic reaction due to other serum, initial encounter |
| T88.6 | Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered |
| T88.6xxA | Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered, initial encounter |
| Chronic idiopathic urticaria | |
| L50.1 | Idiopathic urticaria |
| Cough | |
| R05 | Cough |
| Dermatographic urticaria | |
| L50.3 | Dermatographic urticaria |
| Idiopathic parkinsonism | |
| G20 | Parkinson's disease |
| Insomnia | |
| F51.0 | Insomnia not due to a substance or known physiological condition |
| F51.01 | Primary insomnia |
| F51.02 | Adjustment insomnia |
| F51.03 | Paradoxical insomnia |
| F51.04 | Psychophysiologic insomnia |
| F51.05 | Insomnia due to other mental disorder |
| F51.09 | Other insomnia not due to a substance or known physiological condition |
| G47.0 | Insomnia |
| G47.00 | Insomnia, unspecified |
| G47.01 | Insomnia due to medical condition |
| G47.09 | Other insomnia |
| Motion sickness | |
| T75.3xxA | Motion sickness, initial encounter |
| Nasal congestion | |
| R09.81 | Nasal congestion |
| Nausea | |
| R11 | Nausea and vomiting |
| R11.0 | Nausea |
| R11.2 | Nausea with vomiting, unspecified |
| Nausea and vomiting | |
| R11 | Nausea and vomiting |
| R11.2 | Nausea with vomiting, unspecified |
| Parkinsonism | |
| G20 | Parkinson's disease |
| G21 | Secondary parkinsonism |
| G21.2 | Secondary parkinsonism due to other external agents |
| G21.3 | Postencephalitic parkinsonism |
| G21.4 | Vascular parkinsonism |
| G21.8 | Other secondary parkinsonism |
| G21.9 | Secondary parkinsonism, unspecified |
| Perennial allergic rhinitis | |
| J31.0 | Chronic rhinitis |
| Pruritus of skin | |
| L29.8 | Other pruritus |
| L29.9 | Pruritus, unspecified |
| Seasonal allergic rhinitis | |
| J30.1 | Allergic rhinitis due to pollen |
| J30.2 | Other seasonal allergic rhinitis |
| Sneezing | |
| R06.7 | Sneezing |
| Urticaria | |
| L50 | Urticaria |
| L50.0 | Allergic urticaria |
| L50.1 | Idiopathic urticaria |
| L50.2 | Urticaria due to cold and heat |
| L50.3 | Dermatographic urticaria |
| L50.4 | Vibratory urticaria |
| L50.5 | Cholinergic urticaria |
| L50.6 | Contact urticaria |
| L50.8 | Other urticaria |
| L50.9 | Urticaria, unspecified |
| L56.3 | Solar urticaria |
| O26.86 | Pruritic urticarial papules and plaques of pregnancy (PUPPp) |
| Vertigo | |
| A88.1 | Epidemic vertigo |
| H81.1 | Benign paroxysmal vertigo |
| H81.10 | Benign paroxysmal vertigo, unspecified ear |
| H81.11 | Benign paroxysmal vertigo, right ear |
| H81.12 | Benign paroxysmal vertigo, left ear |
| H81.13 | Benign paroxysmal vertigo, bilateral |
| H81.2 | Vestibular neuronitis |
| H81.20 | Vestibular neuronitis, unspecified ear |
| H81.21 | Vestibular neuronitis, right ear |
| H81.22 | Vestibular neuronitis, left ear |
| H81.23 | Vestibular neuronitis, bilateral |
| H81.3 | Other peripheral vertigo |
| H81.31 | Aural vertigo |
| H81.311 | Aural vertigo, right ear |
| H81.312 | Aural vertigo, left ear |
| H81.313 | Aural vertigo, bilateral |
| H81.319 | Aural vertigo, unspecified ear |
| H81.39 | Other peripheral vertigo |
| H81.391 | Other peripheral vertigo, right ear |
| H81.392 | Other peripheral vertigo, left ear |
| H81.393 | Other peripheral vertigo, bilateral |
| H81.399 | Other peripheral vertigo, unspecified ear |
| H81.4 | Vertigo of central origin |
| H82 | Vertiginous syndromes in diseases classified elsewhere |
| H82.1 | Vertiginous syndromes in diseases classified elsewhere, right ear |
| H82.2 | Vertiginous syndromes in diseases classified elsewhere, left ear |
| H82.3 | Vertiginous syndromes in diseases classified elsewhere, bilateral |
| H82.9 | Vertiginous syndromes in diseases classified elsewhere, unspecified ear |
| R42 | Dizziness and giddiness |
| T75.23 | Vertigo from infrasound |
| T75.23xA | Vertigo from infrasound, initial encounter |
| Vomiting | |
| K91.0 | Vomiting following gastrointestinal surgery |
| R11 | Nausea and vomiting |
| R11.1 | Vomiting |
| R11.10 | Vomiting, unspecified |
| R11.11 | Vomiting without nausea |
| R11.12 | Projectile vomiting |
| R11.13 | Vomiting of fecal matter |
| R11.14 | Bilious vomiting |
| R11.15 | Cyclical vomiting syndrome unrelated to migraine |
| R11.2 | Nausea with vomiting, unspecified |
| 0-9 | A-Z |
|---|---|
| A88.1 | Epidemic vertigo |
| F51.0 | Insomnia not due to a substance or known physiological condition |
| F51.01 | Primary insomnia |
| F51.02 | Adjustment insomnia |
| F51.03 | Paradoxical insomnia |
| F51.04 | Psychophysiologic insomnia |
| F51.05 | Insomnia due to other mental disorder |
| F51.09 | Other insomnia not due to a substance or known physiological condition |
| G20 | Parkinson's disease |
| G20 | Parkinson's disease |
| G21 | Secondary parkinsonism |
| G21.2 | Secondary parkinsonism due to other external agents |
| G21.3 | Postencephalitic parkinsonism |
| G21.4 | Vascular parkinsonism |
| G21.8 | Other secondary parkinsonism |
| G21.9 | Secondary parkinsonism, unspecified |
| G47.0 | Insomnia |
| G47.00 | Insomnia, unspecified |
| G47.01 | Insomnia due to medical condition |
| G47.09 | Other insomnia |
| H10.1 | Acute atopic conjunctivitis |
| H10.10 | Acute atopic conjunctivitis, unspecified eye |
| H10.11 | Acute atopic conjunctivitis, right eye |
| H10.12 | Acute atopic conjunctivitis, left eye |
| H10.13 | Acute atopic conjunctivitis, bilateral |
| H10.44 | Vernal conjunctivitis |
| H10.45 | Other chronic allergic conjunctivitis |
| H16.26 | Vernal keratoconjunctivitis, with limbar and corneal involvement |
| H16.261 | Vernal keratoconjunctivitis, with limbar and corneal involvement, right eye |
| H16.262 | Vernal keratoconjunctivitis, with limbar and corneal involvement, left eye |
| H16.263 | Vernal keratoconjunctivitis, with limbar and corneal involvement, bilateral |
| H16.269 | Vernal keratoconjunctivitis, with limbar and corneal involvement, unspecified eye |
| H81.1 | Benign paroxysmal vertigo |
| H81.10 | Benign paroxysmal vertigo, unspecified ear |
| H81.11 | Benign paroxysmal vertigo, right ear |
| H81.12 | Benign paroxysmal vertigo, left ear |
| H81.13 | Benign paroxysmal vertigo, bilateral |
| H81.2 | Vestibular neuronitis |
| H81.20 | Vestibular neuronitis, unspecified ear |
| H81.21 | Vestibular neuronitis, right ear |
| H81.22 | Vestibular neuronitis, left ear |
| H81.23 | Vestibular neuronitis, bilateral |
| H81.3 | Other peripheral vertigo |
| H81.31 | Aural vertigo |
| H81.311 | Aural vertigo, right ear |
| H81.312 | Aural vertigo, left ear |
| H81.313 | Aural vertigo, bilateral |
| H81.319 | Aural vertigo, unspecified ear |
| H81.39 | Other peripheral vertigo |
| H81.391 | Other peripheral vertigo, right ear |
| H81.392 | Other peripheral vertigo, left ear |
| H81.393 | Other peripheral vertigo, bilateral |
| H81.399 | Other peripheral vertigo, unspecified ear |
| H81.4 | Vertigo of central origin |
| H82 | Vertiginous syndromes in diseases classified elsewhere |
| H82.1 | Vertiginous syndromes in diseases classified elsewhere, right ear |
| H82.2 | Vertiginous syndromes in diseases classified elsewhere, left ear |
| H82.3 | Vertiginous syndromes in diseases classified elsewhere, bilateral |
| H82.9 | Vertiginous syndromes in diseases classified elsewhere, unspecified ear |
| J30.1 | Allergic rhinitis due to pollen |
| J30.1 | Allergic rhinitis due to pollen |
| J30.2 | Other seasonal allergic rhinitis |
| J30.2 | Other seasonal allergic rhinitis |
| J30.5 | Allergic rhinitis due to food |
| J30.8 | Other allergic rhinitis |
| J30.81 | Allergic rhinitis due to animal (cat) (dog) hair and dander |
| J30.89 | Other allergic rhinitis |
| J30.9 | Allergic rhinitis, unspecified |
| J31.0 | Chronic rhinitis |
| K91.0 | Vomiting following gastrointestinal surgery |
| L29.8 | Other pruritus |
| L29.9 | Pruritus, unspecified |
| L50 | Urticaria |
| L50.0 | Allergic urticaria |
| L50.1 | Idiopathic urticaria |
| L50.1 | Idiopathic urticaria |
| L50.2 | Urticaria due to cold and heat |
| L50.3 | Dermatographic urticaria |
| L50.3 | Dermatographic urticaria |
| L50.4 | Vibratory urticaria |
| L50.5 | Cholinergic urticaria |
| L50.6 | Contact urticaria |
| L50.8 | Other urticaria |
| L50.9 | Urticaria, unspecified |
| L56.3 | Solar urticaria |
| O26.86 | Pruritic urticarial papules and plaques of pregnancy (PUPPp) |
| R05 | Cough |
| R06.7 | Sneezing |
| R09.81 | Nasal congestion |
| R11 | Nausea and vomiting |
| R11 | Nausea and vomiting |
| R11 | Nausea and vomiting |
| R11.0 | Nausea |
| R11.1 | Vomiting |
| R11.10 | Vomiting, unspecified |
| R11.11 | Vomiting without nausea |
| R11.12 | Projectile vomiting |
| R11.13 | Vomiting of fecal matter |
| R11.14 | Bilious vomiting |
| R11.15 | Cyclical vomiting syndrome unrelated to migraine |
| R11.2 | Nausea with vomiting, unspecified |
| R11.2 | Nausea with vomiting, unspecified |
| R11.2 | Nausea with vomiting, unspecified |
| R42 | Dizziness and giddiness |
| T75.23 | Vertigo from infrasound |
| T75.23xA | Vertigo from infrasound, initial encounter |
| T75.3xxA | Motion sickness, initial encounter |
| T78.0 | Anaphylactic reaction due to food |
| T78.00 | Anaphylactic reaction due to unspecified food |
| T78.00xA | Anaphylactic reaction due to unspecified food, initial encounter |
| T78.01 | Anaphylactic reaction due to peanuts |
| T78.01xA | Anaphylactic reaction due to peanuts, initial encounter |
| T78.02 | Anaphylactic reaction due to shellfish (crustaceans) |
| T78.02xA | Anaphylactic reaction due to shellfish (crustaceans), initial encounter |
| T78.03 | Anaphylactic reaction due to other fish |
| T78.03xA | Anaphylactic reaction due to other fish, initial encounter |
| T78.04 | Anaphylactic reaction due to fruits and vegetables |
| T78.04xA | Anaphylactic reaction due to fruits and vegetables, initial encounter |
| T78.05 | Anaphylactic reaction due to tree nuts and seeds |
| T78.05xA | Anaphylactic reaction due to tree nuts and seeds, initial encounter |
| T78.06 | Anaphylactic reaction due to food additives |
| T78.06xA | Anaphylactic reaction due to food additives, initial encounter |
| T78.07 | Anaphylactic reaction due to milk and dairy products |
| T78.07xA | Anaphylactic reaction due to milk and dairy products, initial encounter |
| T78.08 | Anaphylactic reaction due to eggs |
| T78.08xA | Anaphylactic reaction due to eggs, initial encounter |
| T78.09 | Anaphylactic reaction due to other food products |
| T78.09xA | Anaphylactic reaction due to other food products, initial encounter |
| T78.2 | Anaphylactic shock, unspecified |
| T78.2xxA | Anaphylactic shock, unspecified, initial encounter |
| T78.40 | Allergy, unspecified |
| T78.40xA | Allergy, unspecified, initial encounter |
| T80.5 | Anaphylactic reaction due to serum |
| T80.51 | Anaphylactic reaction due to administration of blood and blood products |
| T80.51xA | Anaphylactic reaction due to administration of blood and blood products, initial encounter |
| T80.52 | Anaphylactic reaction due to vaccination |
| T80.52xA | Anaphylactic reaction due to vaccination, initial encounter |
| T80.59 | Anaphylactic reaction due to other serum |
| T80.59xA | Anaphylactic reaction due to other serum, initial encounter |
| T88.6 | Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered |
| T88.6xxA | Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered, initial encounter |
Formulary Reference Tool